Role of Psychological Effects on Treatment of Vitiligo in Adolescent Patients in Alsahl Algharbiu Area
DOI:
https://doi.org/10.65405/gtha0867الكلمات المفتاحية:
Vitiligo; Adolescents; Psychological factors; Anxiety; Depression; Treatment outcomeالملخص
Background: Vitiligo is a chronic depigmenting disorder associated with significant psychologicalburden, particularly among adolescents.
Objective: To evaluate the impact of psychological factors on treatment outcomes in adolescentpatients with vitiligo.
Methods: A cross-sectional analytical study was conducted on 60 adolescents aged 12–18 years.Psychological status was assessed using validated measures of anxiety, depression, and self-esteem.Treatment response was clinically evaluated. Statistical analysis was performed using SPSS version 26.
Results: Anxiety and depression showed significant negative correlations with treatment response (r =−0.48, p = 0.001; r = −0.52, p < 0.001). Self-esteem demonstrated a positive correlation (r = 0.45, p =0.002). Regression analysis identified depression as the strongest predictor.
Conclusion: Psychological factors significantly influence treatment outcomes in adolescent vitiligopatients. Integrating psychological care may improve therapeutic outcomes.
التنزيلات
المراجع
1. Taieb A, Picardo M. Clinical practice. Vitiligo. N Engl J Med. 2009;360(2):160–169.
2. Ezzedine K, Eleftheriadou V, Whitton M, van Geel N. Vitiligo. Lancet. 2015;386(9988):74–84.
3. Silverberg JI, Silverberg NB. Association between vitiligo extent and quality of life impairment. JAMA Dermatol. 2013;149(2):159–164.
4. Ongenae K, Van Geel N, De Schepper S, Naeyaert JM. Psychosocial effects of vitiligo. J Eur Acad Dermatol Venereol. 2006;20(1):1–8.
5. Porter JR, Beuf AH, Nordlund JJ, Lerner AB. Psychological reaction to chronic skin disorders: a study of patients with vitiligo. Gen Hosp Psychiatry. 1979;1(1):73–77.
6. Kent G, Al-Abadie M. Psychologic effects of vitiligo: a critical incident analysis. J Am Acad Dermatol. 1996;35(6):895–898.
7. Parsad D, Dogra S, Kanwar AJ. Quality of life in patients with vitiligo. Health Qual Life Outcomes. 2003;1:58.
8. Sampogna F, Tabolli S, Abeni D. Living with vitiligo: impact on quality of life. Br J Dermatol. 2005;152(5):1003–1008.
9. Schallreuter KU, Salem MA, Gibbons NCJ, Rokos H, Wood JM. Stress and vitiligo: neuroendocrine pathways. Exp Dermatol. 2012;21(1):37–42.
10. Picardi A, Pasquini P, Cattaruzza MS, et al. Stressful life events and vitiligo. Psychother Psychosom. 2003;72(3):150–158.
11. Papadopoulos L, Bor R, Legg C. Coping with vitiligo: CBT approach. Br J Med Psychol. 1999;72(3):385–396.
12. Hamidizadeh N, Ranjbar S, Ghanizadeh A. Anxiety and depression in adolescents with vitiligo. J Dermatol Treat. 2016;27(2):172–175.
13. Ezzedine K, Whitton M, Pinart M, et al. Interventions for vitiligo. Cochrane Database Syst Rev. 2016;CD003263.
14. Agila, F. E. S. (2026). Insecticidal effectiveness of seed and leaf oil extract of neem (Azadirachta indica) against larvae and adults of Anopheles stephensi. Al-Farooq Journal of Sciences, 2(3), 429-441.
15. Alboueishi, F. A. A. (2026). Efficacy of Curcumin on Inflammatory Biomarkers in Type 2 Diabetes: A Meta-Analysis of Clinical Trials and Animal Studies Systematic Review & Meta-Analysis (PRISMA 2020) Field: Botany & Complementary Medicine. Al-Farooq Journal of Sciences, 2(2), 15-35.
16. Bergqvist C, Ezzedine K. Vitiligo: pathogenesis and management. Dermatol Clin. 2020;38(1):1–10.
17. Hamron, A. M., Barakat, A. H., Qaed, H. M., & Emran, F. (2026). Evaluation of the antifungal efficacy of Salvia officinalis extract against some clinical oral candidiasis isolates: a comparative study with standard antifungals. Al-Farooq Journal of Sciences, 2(1), 1242-1252.
18. Seneschal J, Boniface K, D'Arino A, Picardo M. Immune mechanisms in vitiligo. Nat Rev Immunol. 2021;21(5):321–333.
19. Alikhan A, Felsten LM, Daly M, Petronic-Rosic V. Vitiligo: review of pathogenesis and treatment. J Am Acad Dermatol. 2011;65(3):473–491.
20. Rodrigues M, Ezzedine K, Hamzavi I, Pandya AG, Harris JE. Vitiligo working group recommendations. JAMA Dermatol. 2017;153(7):666–674
